These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 21923613)

  • 1. Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update.
    Czernik A; Toosi S; Bystryn JC; Grando SA
    Autoimmunity; 2012 Feb; 45(1):111-8. PubMed ID: 21923613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.
    Segura S; Iranzo P; Martínez-de Pablo I; Mascaró JM; Alsina M; Herrero J; Herrero C
    J Am Acad Dermatol; 2007 Jun; 56(6):960-7. PubMed ID: 17368865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders.
    Jolles S
    Clin Exp Dermatol; 2001 Mar; 26(2):127-31. PubMed ID: 11298100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy.
    Kianfar N; Dasdar S; Daneshpazhooh M; Aryanian Z; Goodarzi A
    Exp Dermatol; 2023 Jul; 32(7):934-944. PubMed ID: 37150538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of intravenous immunoglobulin in autoimmune bullous diseases.
    Chee SN; Murrell DF
    Immunol Allergy Clin North Am; 2012 May; 32(2):323-30, viii. PubMed ID: 22560145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bullous autoimmune dermatoses.
    Hofmann SC; Juratli HA; Eming R
    J Dtsch Dermatol Ges; 2018 Nov; 16(11):1339-1358. PubMed ID: 30395395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune blistering dermatoses as systemic diseases.
    Vassileva S; Drenovska K; Manuelyan K
    Clin Dermatol; 2014; 32(3):364-75. PubMed ID: 24767184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subepithelial autoimmune bullous dermatoses disease activity assessment and therapy.
    Montagnon CM; Lehman JS; Murrell DF; Camilleri MJ; Tolkachjov SN
    J Am Acad Dermatol; 2021 Jul; 85(1):18-27. PubMed ID: 33684494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New immunomodulating drugs in autoimmune blistering diseases.
    Korman NJ
    Dermatol Clin; 2001 Oct; 19(4):637-48, viii. PubMed ID: 11705351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases.
    Ishii N; Hashimoto T; Zillikens D; Ludwig RJ
    Clin Rev Allergy Immunol; 2010 Apr; 38(2-3):186-95. PubMed ID: 19557317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of autoimmune blistering diseases: the Pemphigoid diseases.
    Daniel BS; Murrell DF
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1685-1694. PubMed ID: 31087464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bullous dermatosis--treatment up-to-date].
    Komiyama E; Ikeda S
    Nihon Rinsho; 2012 Mar; 70(3):509-17. PubMed ID: 22514935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subepithelial autoimmune blistering dermatoses: Clinical features and diagnosis.
    Montagnon CM; Tolkachjov SN; Murrell DF; Camilleri MJ; Lehman JS
    J Am Acad Dermatol; 2021 Jul; 85(1):1-14. PubMed ID: 33684496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment of autoimmune blistering diseases.
    Kasperkiewicz M; Schmidt E
    Curr Drug Discov Technol; 2009 Dec; 6(4):270-80. PubMed ID: 20025595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders.
    Jolles S
    Clin Exp Immunol; 2002 Sep; 129(3):385-9. PubMed ID: 12197877
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab in refractory autoimmune bullous diseases.
    Schmidt E; Hunzelmann N; Zillikens D; Bröcker EB; Goebeler M
    Clin Exp Dermatol; 2006 Jul; 31(4):503-8. PubMed ID: 16716150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune blistering diseases in children.
    Lara-Corrales I; Pope E
    Semin Cutan Med Surg; 2010 Jun; 29(2):85-91. PubMed ID: 20579597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune bullous diseases in childhood.
    Sansaricq F; Stein SL; Petronic-Rosic V
    Clin Dermatol; 2012; 30(1):114-27. PubMed ID: 22137235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular manifestations of blistering diseases.
    Elchahal S; Kavosh ER; Chu DS
    Immunol Allergy Clin North Am; 2008 Feb; 28(1):119-36, vii. PubMed ID: 18282549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
    Rütter A; Luger TA
    Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.